Home / Inspections / 1251717

FDA Inspection 1251717 — Blood Bank Of Delmarva, a Division of New York Blood Center, Inc.

Blood Bank Of Delmarva, a Division of New York Blood Center, Inc. — FEI 2577603

The FDA completed an inspection of Blood Bank Of Delmarva, a Division of New York Blood Center, Inc. on September 24, 2024 in Newark, DE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 24, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Newark, DE (United States)

Facility

Other inspections at this facility

  • 1117609 (VAI Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1046316 (NAI Tue Feb 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 964016 (VAI Tue Feb 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 863672 (NAI Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 763213 (VAI Tue Jan 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources